TWD 30.0
(-1.48%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 889.91 Million TWD | 73.86% |
2022 | 511.85 Million TWD | 10.47% |
2021 | 463.34 Million TWD | 12.46% |
2020 | 412.01 Million TWD | 16.54% |
2019 | 353.53 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 301.48 Million TWD | 30.32% |
2024 Q2 | 301.48 Million TWD | 0.0% |
2023 Q4 | 231.33 Million TWD | 0.0% |
2023 FY | 889.91 Million TWD | 73.86% |
2023 Q3 | 231.33 Million TWD | 8.3% |
2023 Q1 | 213.61 Million TWD | 97.09% |
2023 Q2 | 213.61 Million TWD | 0.0% |
2022 Q4 | 108.38 Million TWD | 0.0% |
2022 FY | 511.85 Million TWD | 10.47% |
2022 Q3 | 108.38 Million TWD | 0.0% |
2021 FY | 463.34 Million TWD | 12.46% |
2020 FY | 412.01 Million TWD | 16.54% |
2019 FY | 353.53 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Allied Biotech Corporation | 720.43 Million TWD | -23.525% |
GeneFerm Biotechnology Co., Ltd. | 793.77 Million TWD | -12.112% |
Easywell Biomedicals, Inc. | 271.62 Million TWD | -227.622% |
TTY Biopharm Company Limited | 5.5 Billion TWD | 83.836% |
Synmosa Biopharma Corporation | 5.14 Billion TWD | 82.688% |
Orient EuroPharma Co., Ltd. | 4.59 Billion TWD | 80.62% |
Center Laboratories, Inc. | 1.39 Billion TWD | 36.162% |
Tien Liang BioTech Co., Ltd. | 459.99 Million TWD | -93.462% |
InnoPharmax Inc. | 46.07 Million TWD | -1831.526% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 606.71 Million TWD | -46.678% |
Excelsior Biopharma Inc. | 771.56 Million TWD | -15.339% |
DV Biomed Co., Ltd. | 1.53 Billion TWD | 42.152% |
Foresee Pharmaceuticals Co., Ltd. | 195.03 Million TWD | -356.276% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 19.561% |
UniPharma Co., Ltd. | 103.22 Million TWD | -762.134% |
Anxo Pharmaceutical Co., Ltd. | 939.94 Million TWD | 5.323% |
Alar Pharmaceuticals Inc. | 469.27 Million TWD | -89.637% |
Winston Medical Supply Co., Ltd. | 709.07 Million TWD | -25.503% |
Mercury Biopharmaceutical Corporation | 1.03 Million TWD | -86048.306% |
Bioray Biotech Co., Ltd | 191.83 Million TWD | -363.907% |
TSH Biopharm Corporation Limited | 810.91 Million TWD | -9.741% |